Glycomimetics Glyc Q2 2018 Earnings Conference Call Transcript | Latest News RSS feed

Glycomimetics Glyc Q2 2018 Earnings Conference Call Transcript - Latest News


GlycoMimetics (GLYC) Q2 2018 Earnings Conference Call Transcript

Image source: The Motley Fool. GlycoMimetics (NASDAQ: GLYC) Q2 2018 Earnings Conference Call Aug. 10, 2018 8:30 a.m. ET Operator Good morning, and thank you all for joining the GlycoMimetics call. [Op... read more

GlycoMimetics' (GLYC) CEO Rachel King on Q1 2018 Results - Earnings Call Transcript

GlycoMimetics (NASDAQ:GLYC) Q1 2018 Earnings Conference Call May 3, 2018 8:30 AM ET Executives Shari Annes - IR Rachel King - CEO Brian Hahn - CFO Helen Thackray - SVP, Clinical Development and CMO An... read more

GlobeNewswire - KTRE.com | Lufkin and Nacogdoches, Texas

RUSHA), GlycoMimetics, Inc. (NASDAQ:GLYC), Federal Signal Corporation (NYSE:FSS), ATN International, Inc. (NASDAQ:ATNI), and Novavax, Inc. (NASDAQ:NVAX), including updated fundamental summaries, cons. ... read more

Looking for another news?


FS Investment Corp Shares Outstanding

Shares outstanding represents a company's market value spread across the amount of shares outstanding. The amount of shares outstanding is frequently used in ratios such as Earnings Per Share. read more


GlycoMimetics, Inc. (GLYC)

GlycoMimetics, Inc. (GLYC), a biopharmaceutical company focused on discovering and developing novel small-molecule drug candidates to treat rare diseases, announced today that the Japan Patent Office ... read more

FS Investment Corporation (FSIC)

NEW YORK, NY / ACCESSWIRE / August 10, 2018 / FS Investment Corporation (NYSE: FSIC ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 10, 2018 at 10:00 AM East... read more

GlycoMimetics, Inc. (GLYC)

NEW YORK, Aug. 31, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ... read more

FS Investment Corporation (FSIC)

NEW YORK, Aug. 31, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ... read more

GlycoMimetics, Inc. (GLYC)

NEW YORK, Aug. 31, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ... read more

GlycoMimetics, Inc. (GLYC)

NEW YORK, Aug. 31, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ... read more

GlycoMimetics, Inc. (GLYC)

GlycoMimetics, Inc. (GLYC), a biopharmaceutical company focused on discovering and developing novel small-molecule drug candidates to treat rare diseases, announced today that the Japan Patent Office ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us